PRECISION OPTICS CORPORATION, INC.
Business
PRECISION OPTICS CORPORATION, INC. is a developer and manufacturer of advanced optical instruments serving medical and defense/aerospace markets. It produces traditional and digital endoscopes and endocouplers, Microprecision™ lenses, micro medical cameras, custom imaging and illumination products, optical components and assemblies, and the Unity imaging platform for reusable and single‑use visualization systems. Operations are organized into systems manufacturing, engineering and product development, Ross Optical components and assemblies, and a micro‑optics laboratory. The company markets primarily to U.S. medical device OEMs and defense/aerospace customers via direct sales, trade shows, referrals and online channels, and sources components from domestic and international suppliers.
Summary from filing dated 2025-09-29
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Revenues | 19 | 19 | 21 | 16 | 11 | |
| Cost of goods sold | 16 | 13 | 13 | 11 | 7 | |
| Gross profit | 3 | 6 | 8 | 5 | 3 | |
| Research and development expenses, net | 1 | 981,781 | 992,375 | 666,479 | 624,253 | |
| Selling, general and administrative expenses | 8 | 8 | 7 | 6 | 4 | |
| Total operating expenses | 9 | 9 | 8 | 6 | 4 | |
| Operating loss | −6 | −3 | −638,548 | −2 | −905,583 | |
| Interest expense | −227,019 | −225,108 | — | −155,658 | −5,302 | |
| Loss before provision for income taxes | −6 | −3 | −142,677 | −927,464 | −101,923 | |
| Provision for income taxes | 1,936 | 1,936 | 1,936 | 952 | 912 | |
| Net loss | −6 | −3 | −144,613 | −928,416 | −102,835 | |
| Income (Loss) Per Share, Basic | −0.85 | −0.49 | −0.03 | −0.06 | −0.01 | |
| Income (Loss) Per Share, Fully Diluted | −0.85 | −0.49 | −0.03 | −0.06 | −0.01 | |
| Weighted Average Common Shares Outstanding, Basic | 7 | 6 | 6 | 16 | 13 | |
| Weighted Average Common Shares Outstanding, Basic, Fully Diluted | 7 | 6 | 6 | 16 | 13 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 2 | 405,278 | 3 | 605,749 | 861,650 | |
| Accounts receivable, net of allowance for credit losses of $80,192 at June 30, 2025 and $118,872 at June 30, 2024 | 4 | 4 | 4 | 3 | 2 | |
| Inventories, net | 4 | 3 | 3 | 3 | 2 | |
| Prepaid expenses | 385,390 | 299,364 | 249,681 | 213,448 | 150,635 | |
| Total current assets | 10 | 7 | 10 | 7 | 5 | |
| Machinery and equipment | 3 | 3 | 3 | 3 | 3 | |
| Leasehold improvements | 871,356 | 810,914 | 825,752 | 843,903 | 792,723 | |
| Furniture and fixtures | 538,428 | 416,425 | 242,865 | 219,999 | 178,640 | |
| Total fixed assets | 5 | 5 | 4 | 4 | 4 | |
| LessAccumulated depreciation and amortization | 4 | 4 | 4 | 4 | 3 | |
| Net fixed assets | 533,792 | 493,573 | 433,520 | 627,471 | 594,252 | |
| Operating lease right-of-use asset | 141,825 | 189,999 | 358,437 | 517,725 | 61,247 | |
| Patents, net | 232,493 | 286,559 | 265,111 | 229,398 | 141,702 | |
| Goodwill | 9 | 9 | 9 | 9 | 687,664 | |
| Total other assets | 9 | 9 | 9 | — | — | |
| TOTAL ASSETS | 20 | 17 | 20 | 17 | 6 | |
| Revolving line of credit | 0 | 1 | 0 | — | — | |
| Current portion of capital lease obligation | 27,368 | 41,113 | 43,209 | 40,705 | 38,347 | |
| Current maturities of long-term debt | 577,898 | 276,928 | 513,259 | 367,714 | 0 | |
| Accounts payable | 3 | 1 | 2 | 2 | 1 | |
| Customer advances | 2 | 1 | 1 | 905,113 | 450,084 | |
| Accrued compensation and other | 764,004 | 840,662 | 927,521 | 716,702 | 589,616 | |
| Operating lease liability | 50,995 | 178,450 | 168,677 | — | 61,247 | |
| Total current liabilities | 6 | 5 | 5 | 5 | 3 | |
| Capital lease obligation, net of current portion | 0 | 27,369 | 68,482 | 111,691 | 152,397 | |
| Long-term debt, net of current maturities | 1 | 2 | 2 | 2 | 0 | |
| Operating lease liability, net of current portion | 90,954 | 11,549 | 189,760 | 367,160 | 0 | |
| Total liabilities | 8 | 7 | 8 | — | — | |
| Common stock, $0.01 par value: 50,000,000 shares authorized; issued and outstanding 7,714,701 shares at June 30, 2025 and 6,073,939 shares at June 30, 2024 | 77,147 | 60,739 | 60,665 | 169,150 | 132,825 | |
| Additional paid-in capital | 69 | 61 | 60 | 57 | 50 | |
| Accumulated deficit | −57 | −51 | −48 | −48 | −47 | |
| Total stockholders equity | 12 | 10 | 12 | 9 | 3 | |
| TOTAL LIABILITIES AND STOCKHOLDERS EQUITY | 20 | 17 | 20 | 17 | 6 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 212,439 | 212,382 | 210,735 | 190,221 | 146,799 | |
| Stock-based compensation expense | 1 | 959,784 | 919,032 | 915,494 | 733,930 | |
| Non-cash legal expense | 34,881 | 0 | — | — | — | |
| Non-cash interest expense | 11,563 | 17,504 | 4,087 | 55,017 | 0 | |
| Non-cash operating lease expense | 124 | 0 | — | — | — | |
| Accounts receivable, net | −791,239 | 361,916 | −1 | −108,140 | −397,318 | |
| Inventories | −694,012 | −91,884 | 245,931 | −680,744 | 311,849 | |
| Prepaid expenses | −86,026 | −49,683 | −36,233 | 19,312 | −16,928 | |
| Accounts payable | 2 | −1 | 193,089 | 819,284 | 139,144 | |
| Contract liabilities | 649,579 | −2,340 | 269,577 | −371,650 | 33,025 | |
| Accrued compensation and other | −76,658 | −104,363 | 206,732 | — | 7,846 | |
| Net cash used in operating activities | −4 | −3 | −81,090 | −933,371 | 46,550 | |
| Reclassification/additional patent costs | −6,264 | −21,448 | — | — | — | |
| Purchases of property and equipment | −227,209 | −272,435 | −16,784 | −113,197 | −75,924 | |
| Net cash used in investing activities | −233,473 | −293,883 | −52,497 | −407,802 | −122,397 | |
| Payment of capital lease obligations | −41,114 | −43,209 | −40,705 | −38,349 | −58,804 | |
| Principal payments of long-term debt | −280,440 | −513,259 | −367,341 | −247,002 | 0 | |
| Payment of debt issuance costs | −40,000 | 0 | — | — | — | |
| (Repayments)/Borrowings on line of credit | −1 | 1 | 0 | — | — | |
| Gross proceeds from registered direct offerings of common stock | 6 | 0 | 2 | 2 | 0 | |
| Stock issued for services | 151,698 | 0 | — | — | — | |
| Gross proceeds from exercise of stock options | 89,050 | 12,789 | 12,397 | 63,290 | 28,271 | |
| Net cash provided by financing activities | 5 | 456,321 | 2 | 1 | −197,200 | |
| Net increase (decrease) in cash and cash equivalents | 1 | −3 | 2 | −255,901 | −273,047 | |
| Cash paid during the year for income taxes | 1,936 | 1,936 | 1,936 | 912 | 2,165 | |
| Cash paid during the year for interest | 216,456 | 207,604 | — | — | — | |
| Operating right-of-use assets obtained in exchange for operating lease liabilities | 133,650 | 0 | — | — | — |